"Small molecule minimally invasive technology" makes patients at different stages of illness move towards new life through the standardized treatment mode of early cure, mid-term control and late compensation. Through the long-term scientific follow-up of the clinical treatment effect of tens of thousands of patients, all the indicators and data of "small molecule minimally invasive technology" have achieved excellent results, which has been highly praised by the national authorities and won the title of national medical research patent technology in 20 13, which is not only "small molecule minimally invasive technology"
Innovating scientific and technological achievements and leading the new standard of standardized treatment of ankylosing spondylitis and rheumatoid diseases in China
With its unique advantages, "small molecule minimally invasive technology" has solved the disadvantages of traditional therapy, such as slow response, large side effects and easy recurrence. It is reported that this technology is the only nationally certified treatment technology in the treatment of ankylosing spondylitis and rheumatoid diseases in China, which provides a new standard for standardized treatment of ankylosing spondylitis.
On the afternoon of July 28th, 20 13, the launching ceremony of "National Patent' Small Molecule Minimally Invasive Technique for Ankylosing Spondylitis' Achievement Exhibition and Clinical Promotion Press Conference" and "Healthy Chinese Dream to Help Poor Patients with Osteomyelitis" was grandly held in the lecture hall of the National Health and Family Planning Commission.
Cao, former vice minister of health and honorary president of China Hospital Association; Professor Yang Minghui, Vice President of Chinese Medicine Association and President of PLA Chinese Medicine Association; Member Chinese People's Political Consultative Conference, Executive Committee of All-China Women's Federation and Vice Chairman of chinese primary health care Foundation; Yu Shenglong, former deputy director of state administration of traditional chinese medicine; Micheal Lee, Vice President of Chinese Medicine Association; Professor Luo Xianzheng; Academician of Chinese Academy of Traditional Chinese Medicine, Member of Beijing Rheumatology Branch of China Society of Traditional Chinese Medicine, Member of Rheumatology Branch of Beijing Society of Integrated Traditional Chinese and Western Medicine, He Xiaxiu, as well as experts from all over the country, representatives of rehabilitation patients and nearly 100 authoritative media concerned about this activity attended the meeting.